Cargando…
Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
As protein binding of uremic toxins is not well understood, neither in chronic kidney disease (CKD) progression, nor during a hemodialysis (HD) session, we studied protein binding in two cross-sectional studies. Ninety-five CKD 2 to 5 patients and ten stable hemodialysis patients were included. Bloo...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626712/ https://www.ncbi.nlm.nih.gov/pubmed/26426048 http://dx.doi.org/10.3390/toxins7103933 |
_version_ | 1782398149198872576 |
---|---|
author | Deltombe, Olivier Van Biesen, Wim Glorieux, Griet Massy, Ziad Dhondt, Annemieke Eloot, Sunny |
author_facet | Deltombe, Olivier Van Biesen, Wim Glorieux, Griet Massy, Ziad Dhondt, Annemieke Eloot, Sunny |
author_sort | Deltombe, Olivier |
collection | PubMed |
description | As protein binding of uremic toxins is not well understood, neither in chronic kidney disease (CKD) progression, nor during a hemodialysis (HD) session, we studied protein binding in two cross-sectional studies. Ninety-five CKD 2 to 5 patients and ten stable hemodialysis patients were included. Blood samples were taken either during the routine ambulatory visit (CKD patients) or from blood inlet and outlet line during dialysis (HD patients). Total (C(T)) and free concentrations were determined of p-cresylglucuronide (pCG), hippuric acid (HA), indole-3-acetic acid (IAA), indoxyl sulfate (IS) and p-cresylsulfate (pCS), and their percentage protein binding (%PB) was calculated. In CKD patients, %PB/C(T) resulted in a positive correlation (all p < 0.001) with renal function for all five uremic toxins. In HD patients, %PB was increased after 120 min of dialysis for HA and at the dialysis end for the stronger (IAA) and the highly-bound (IS and pCS) solutes. During one passage through the dialyzer at 120 min, %PB was increased for HA (borderline), IAA, IS and pCS. These findings explain why protein-bound solutes are difficult to remove by dialysis: a combination of the fact that (i) only the free fraction can pass the filter and (ii) the equilibrium, as it was pre-dialysis, cannot be restored during the dialysis session, as it is continuously disturbed. |
format | Online Article Text |
id | pubmed-4626712 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-46267122015-11-12 Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis Deltombe, Olivier Van Biesen, Wim Glorieux, Griet Massy, Ziad Dhondt, Annemieke Eloot, Sunny Toxins (Basel) Article As protein binding of uremic toxins is not well understood, neither in chronic kidney disease (CKD) progression, nor during a hemodialysis (HD) session, we studied protein binding in two cross-sectional studies. Ninety-five CKD 2 to 5 patients and ten stable hemodialysis patients were included. Blood samples were taken either during the routine ambulatory visit (CKD patients) or from blood inlet and outlet line during dialysis (HD patients). Total (C(T)) and free concentrations were determined of p-cresylglucuronide (pCG), hippuric acid (HA), indole-3-acetic acid (IAA), indoxyl sulfate (IS) and p-cresylsulfate (pCS), and their percentage protein binding (%PB) was calculated. In CKD patients, %PB/C(T) resulted in a positive correlation (all p < 0.001) with renal function for all five uremic toxins. In HD patients, %PB was increased after 120 min of dialysis for HA and at the dialysis end for the stronger (IAA) and the highly-bound (IS and pCS) solutes. During one passage through the dialyzer at 120 min, %PB was increased for HA (borderline), IAA, IS and pCS. These findings explain why protein-bound solutes are difficult to remove by dialysis: a combination of the fact that (i) only the free fraction can pass the filter and (ii) the equilibrium, as it was pre-dialysis, cannot be restored during the dialysis session, as it is continuously disturbed. MDPI 2015-09-28 /pmc/articles/PMC4626712/ /pubmed/26426048 http://dx.doi.org/10.3390/toxins7103933 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Deltombe, Olivier Van Biesen, Wim Glorieux, Griet Massy, Ziad Dhondt, Annemieke Eloot, Sunny Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis |
title | Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis |
title_full | Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis |
title_fullStr | Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis |
title_full_unstemmed | Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis |
title_short | Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis |
title_sort | exploring protein binding of uremic toxins in patients with different stages of chronic kidney disease and during hemodialysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626712/ https://www.ncbi.nlm.nih.gov/pubmed/26426048 http://dx.doi.org/10.3390/toxins7103933 |
work_keys_str_mv | AT deltombeolivier exploringproteinbindingofuremictoxinsinpatientswithdifferentstagesofchronickidneydiseaseandduringhemodialysis AT vanbiesenwim exploringproteinbindingofuremictoxinsinpatientswithdifferentstagesofchronickidneydiseaseandduringhemodialysis AT glorieuxgriet exploringproteinbindingofuremictoxinsinpatientswithdifferentstagesofchronickidneydiseaseandduringhemodialysis AT massyziad exploringproteinbindingofuremictoxinsinpatientswithdifferentstagesofchronickidneydiseaseandduringhemodialysis AT dhondtannemieke exploringproteinbindingofuremictoxinsinpatientswithdifferentstagesofchronickidneydiseaseandduringhemodialysis AT elootsunny exploringproteinbindingofuremictoxinsinpatientswithdifferentstagesofchronickidneydiseaseandduringhemodialysis |